Additionally, we observed that lung cancer cells acquire resistance to 4G EGFR-TKI using their “favorite” off-target resistance mechanisms after acquisition of resistance to 1G–3G EGFR-TKIs. The gene discussed is EGFR; the disease is lung cancer.